IRIS Accounts Production v18.2.0.360 03698954 Board of Directors 1.11.16 31.10.17 31.10.17 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure036989542016-10-31036989542017-10-31036989542016-11-012017-10-31036989542015-10-31036989542015-11-012016-10-31036989542016-10-3103698954ns15:EnglandWales2016-11-012017-10-3103698954ns14:PoundSterling2016-11-012017-10-3103698954ns10:Director12016-11-012017-10-3103698954ns10:PrivateLimitedCompanyLtd2016-11-012017-10-3103698954ns10:SmallEntities2016-11-012017-10-3103698954ns10:AuditExempt-NoAccountantsReport2016-11-012017-10-3103698954ns10:SmallCompaniesRegimeForDirectorsReport2016-11-012017-10-3103698954ns10:SmallCompaniesRegimeForAccounts2016-11-012017-10-3103698954ns10:FullAccounts2016-11-012017-10-3103698954ns10:Director22016-11-012017-10-3103698954ns10:CompanySecretary12016-11-012017-10-3103698954ns10:RegisteredOffice2016-11-012017-10-3103698954ns5:CurrentFinancialInstruments2017-10-3103698954ns5:CurrentFinancialInstruments2016-10-3103698954ns5:ShareCapital2017-10-3103698954ns5:ShareCapital2016-10-3103698954ns5:RetainedEarningsAccumulatedLosses2017-10-3103698954ns5:RetainedEarningsAccumulatedLosses2016-10-3103698954ns5:LeaseholdImprovements2016-11-012017-10-3103698954ns5:PlantMachinery2016-11-012017-10-3103698954ns5:FurnitureFittings2016-11-012017-10-3103698954ns5:MotorVehicles2016-11-012017-10-3103698954ns5:ComputerEquipment2016-11-012017-10-3103698954ns5:LeaseholdImprovements2016-10-3103698954ns5:PlantMachinery2016-10-3103698954ns5:FurnitureFittings2016-10-3103698954ns5:LeaseholdImprovements2017-10-3103698954ns5:PlantMachinery2017-10-3103698954ns5:FurnitureFittings2017-10-3103698954ns5:LeaseholdImprovements2016-10-3103698954ns5:PlantMachinery2016-10-3103698954ns5:FurnitureFittings2016-10-3103698954ns5:MotorVehicles2016-10-3103698954ns5:ComputerEquipment2016-10-3103698954ns5:MotorVehicles2017-10-3103698954ns5:ComputerEquipment2017-10-3103698954ns5:MotorVehicles2016-10-3103698954ns5:ComputerEquipment2016-10-3103698954ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-10-3103698954ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-10-3103698954ns5:DeferredTaxation2016-10-3103698954ns5:DeferredTaxation2017-10-31


REGISTERED NUMBER: 03698954 (England and Wales)










A & M PHARMACIES LIMITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2017






A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2017




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


A & M PHARMACIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 OCTOBER 2017







DIRECTORS: Mr A L Hindocha
Mrs M A Hindocha





SECRETARY: Mrs M A Hindocha





REGISTERED OFFICE: 126 Sutherland Avenue
Coventry
West Midlands
CV5 7NJ





REGISTERED NUMBER: 03698954 (England and Wales)





ACCOUNTANTS: Shah & Co (Accountants) Ltd
Chartered Certified Accountants
Cash's Business Centre
1st Floor
228 Widdrington Road
Coventry
West Midlands
CV1 4PB

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

BALANCE SHEET
31 OCTOBER 2017

31.10.17 31.10.16
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 240,156 278,974

CURRENT ASSETS
Stocks 101,958 103,223
Debtors 5 1,043,207 537,245
Cash at bank and in hand 88,538 467,273
1,233,703 1,107,741
CREDITORS
Amounts falling due within one year 6 444,581 420,730
NET CURRENT ASSETS 789,122 687,011
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,029,278

965,985

PROVISIONS FOR LIABILITIES 7 15,211 17,252
NET ASSETS 1,014,067 948,733

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,013,967 948,633
SHAREHOLDERS' FUNDS 1,014,067 948,733

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 27 July 2018 and were signed on its behalf by:



Mr A L Hindocha - Director


A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2017

1. STATUTORY INFORMATION

A & M Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

First year adoption of Financial Reporting Standard 102 ( FRS 102) Section 1A
These financial statements for the year ended 31 October 2017 are the first that are prepared in accordance with
FRS 102 Section 1A. The previous financial statements were prepared in accordance with UK GAAP, the date of
transition to FRS 102 Section 1A is 1 November 2015.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 15% on reducing balance
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2017

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings
£    £    £   
COST
At 1 November 2016 318,688 42,315 458,995
At 31 October 2017 318,688 42,315 458,995
DEPRECIATION
At 1 November 2016 193,163 31,801 340,982
Charge for year 18,829 1,578 17,702
Eliminated on disposal - - -
At 31 October 2017 211,992 33,379 358,684
NET BOOK VALUE
At 31 October 2017 106,696 8,936 100,311
At 31 October 2016 125,525 10,514 118,013

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 November 2016 20,889 64,173 905,060
Additions 6,490 - 6,490
Disposals (19,389 ) - (19,389 )
At 31 October 2017 7,990 64,173 892,161
DEPRECIATION
At 1 November 2016 18,693 41,447 626,086
Charge for year 1,633 3,409 43,151
Eliminated on disposal (17,232 ) - (17,232 )
At 31 October 2017 3,094 44,856 652,005
NET BOOK VALUE
At 31 October 2017 4,896 19,317 240,156
At 31 October 2016 2,196 22,726 278,974

A & M PHARMACIES LIMITED (REGISTERED NUMBER: 03698954)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2017

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.17 31.10.16
£    £   
Trade debtors 164,471 119,936
Other debtors 878,736 417,309
1,043,207 537,245

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.17 31.10.16
£    £   
Trade creditors 368,368 350,076
Taxation and social security 53,905 55,366
Other creditors 22,308 15,288
444,581 420,730

7. PROVISIONS FOR LIABILITIES
31.10.17 31.10.16
£    £   
Deferred tax 15,211 17,252

Deferred
tax
£   
Balance at 1 November 2016 17,252
Decrease in provision (2,041 )
Balance at 31 October 2017 15,211

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year rent was paid to the directors Mr. & Mrs. A Hindocha on normal commercial terms. The rent
was for the premises at Mount Nod in Coventry, the amounts paid were £15,000 (2016- £15,000).

Included within the creditors , the amount owed to the directors is £ 1,366 (2016 £ 1,496 ).These loans are
interest free and with no fixed date of repayment.

9. RELATED PARTY DISCLOSURES

During the year, total dividends of £122,000 (2016 - £124,000) were paid to the directors .

10. ULTIMATE CONTROLLING PARTY

The controlling party is Mr & Mrs Hindocha.